The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%Wallstreetcn·Feb 6 at 02:24 AM000554+1.74%301111-6.21%
Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio Valley and LSPG rising over 10%Wallstreetcn·Feb 5 at 07:27 PM301111-6.21%002864-1.94%
LSPG: Hehe Investment reduced its holdings by 2.1839 million shares on December 3rd-4th36Kr·Dec 5, 2025 at 05:27 AM301111-6.21%
LSPG: Shareholder Yinkang Management reduced its stake by 1.1775625% in the companyZhitong·Sep 26, 2025 at 07:15 AM301111-6.21%
LSPG: Loss of RMB 7.2249 million in the first half of the year, turning from profit to loss year-on-yearZhitong·Aug 26, 2025 at 05:16 AM301111-6.21%
LSPG's two shareholders plan to reduce their holdings by a total of no more than 6%Zhitong·Jul 4, 2025 at 06:21 AM301111-6.21%
LSPG: Harmony Investment plans to reduce its holdings of the company's shares by no more than 3.00%Zhitong·Jul 4, 2025 at 05:58 AM301111-6.21%
LSPG released its first-quarter performance, turning from profit to a loss of 3.4417 million yuanZhitong·Apr 25, 2025 at 07:18 AM301111-6.21%
LSPG: Net profit in 2024 decreased by 87.57% year-on-yearZhitong·Apr 25, 2025 at 06:24 AM301111-6.21%
LSPG's major shareholder, Harmony Investment, has completed the reduction of 302,000 sharesZhitong·Apr 8, 2025 at 05:52 PM301111-6.21%
LSPG has been cumulatively reduced by shareholders Hehe Investment by 1.698 million sharesZhitong·Mar 24, 2025 at 04:24 AM301111-6.21%
Chinese medicine stocks surged, LSPG rose over 6%, Longshenrongfa Pharmaceutical Industry rose over 5%Zhitong·Mar 20, 2025 at 01:12 AM300534+1.21%301111-6.21%
LSPG plans to increase its investment in its holding subsidiary WanNianQing Pharmaceutical by 22.8 million yuanZhitong·Jan 27, 2025 at 01:58 AM301111-6.21%
LSPG: Ginseng and Astragalus Blood Sugar Reduction Tablets are expected to be selected for the centralized procurement of the National Traditional Chinese Medicine Procurement AllianceZhitong·Jan 2, 2025 at 02:27 AM301111-6.21%
